Docoh
Loading...

ISEE IVERIC bio

GRANT
Utility
Carbocyclic prolinamide derivatives
17 Aug 21
This invention is directed to novel carbocyclic prolinamide derivatives of Formula (I), and pharmaceutically acceptable salts, solvates, solvates of the salt and prodrugs thereof, useful in the prevention (e.g., delaying the onset of or reducing the risk of developing) and treatment (e.g., controlling, alleviating, or slowing the progression of) of age-related macular degeneration (AMD) and related diseases of the eye.
Robert Gomez, Jinyue Ding, Renata Marcella Oballa, David Andrew Powell
Filed: 6 Jan 20
APP
Utility
a Method for Treating or Preventing Idiopathic Polypoidal Choroidal Vasculopathy (Ipcv)
10 Jun 21
A method for treating or preventing idiopathic polypoidal choroidal vasculopathy is provided comprising intravitreal injections of Zimura™ (or another anti-CS agent) and Eylea® (or another VEGF antagonist).
Kourous Rezaei
Filed: 16 Nov 18
APP
Utility
Carbocyclic Prolinamide Derivatives
9 Dec 20
This invention is directed to novel carbocyclic prolinamide derivatives of Formula (I), and pharmaceutically acceptable salts, solvates, solvates of the salt and prodrugs thereof, useful in the prevention (e.g., delaying the onset of or reducing the risk of developing) and treatment (e.g., controlling, alleviating, or slowing the progression of) of age-related macular degeneration (AMD) and related diseases of the eye.
Robert Gomez, Jinyue Ding, Renata Marcella Oballa, David Andrew Powell
Filed: 5 Jan 20
GRANT
Utility
Aliphatic prolinamide derivatives
3 Aug 20
Austin Chih-Yu Chen, Robert Gomez, Renata Marcella Oballa, David Andrew Powell, Jeffrey Roger Roppe, Thomas Jon Seiders, Tao Sheng
Filed: 14 Jun 17
APP
Utility
Methods for Treating or Preventing Ophthalmological Conditions
18 Dec 19
The present invention relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering Antagonist A or another pharmaceutically acceptable salt thereof, optionally in combination with another treatment, to a subject in need thereof.
Samir Patel, Richard Everett, Douglas Brooks, Shane Xinxin Tian
Filed: 5 Jun 19
  • 1
Patents are sorted by USPTO publication date, most recent first